“The Senate on Wednesday approved the nomination of Robert Califf, MD, to head the FDA, thwarting an effort by a small group of senators to block his nomination over Califf’s ties to the pharmaceutical industry.
The 89-4 confirmation vote followed a procedural vote of 80-6 on Monday to allow Califf’s nomination to go forward.
Physician and healthcare groups reacted positively to the Senate vote. “Dr. Califf is an acclaimed leader in the cardiovascular community who brings impressive medical knowledge, clinical research experience and leadership capabilities to the FDA,” said American College of Cardiology President Kim Allan Williams Sr., MD, in a statement. “He has made important contributions to the field of medicine and has the vision required to lead the FDA in its efforts to promote and protect public health. Dr. Califf is the right person to lead the FDA.”
Source: MedPageToday.com – February 24, 2016